Dorsal root ganglion (DRG) neurons detect sensory inputs and are crucial for pain processing.
Introduction (544 words)
Nociceptors within the dorsal root ganglia (DRG) or trigeminal ganglia (TG) are the first neurons in the pain pathway and are responsible for the detection of damaging and potentially damaging stimuli [17; 62] . These neurons are crucial contributors to chronic pain disorders ranging from inflammatory to neuropathic pain [46; 48] . Because of their importance in clinical pain disorders, these neurons are frequently studied to gain insight into mechanisms that drive chronic pain and to develop better treatment strategies. Traditionally, investigators have studied rodent nociceptors in vitro as dissociated cell cultures prepared from DRG or TG. More recently, investigators have also started to study DRG nociceptors from human organ donors and surgical patients [14; 39; 47; 50; 51; 59; 70] . This creates a "clinical bridge" for advancing mechanisms or therapeutics from rodents toward the clinic. These models have many advantages; cultures can easily be used for electrophysiology, Ca 2+ imaging, biochemical, or other functional studies. These studies have unquestionably advanced the field of pain neurobiology and sensory transduction.
Despite the widespread use of this model system [35] , many investigators are skeptical of the degree to which these cells in dissociated culture accurately reflect the status of nociceptors in vivo. Several studies have analyzed the genome wide RNA profiles of these cultures [25; 43] , but not in the context of changes with respect to the intact ganglia. A previous study by Thakur et al [54] contrasted RNA sequencing (RNA-seq) profiles of intact DRGs with unsorted, dissociated DRGs in the context of profiling magnetically sorted, neuronally enriched dissociated DRGs. The study found few differences (7,630 genes were comparably expressed in both, while 424 were differentially expressed) between intact DRG tissue and unsorted, acutely dissociated DRG, suggesting that the process of dissociation does not dramatically alter the molecular phenotype. While some studies have compared expression of a single gene or a handful of genes in these in vitro cultures vs. the intact ganglia (like the comparison of Npr3 expression in Goswami et al [22] ), we are unaware of any study that has used genome-wide assays to study how gene expression might be altered from native to cultured DRG conditions. In this study we addressed this question by comparing intact versus cultured DRG from human donors and mice using RNA-seq technology. We designed a series of experiments to study how native DRG transcriptomes differ from cultured ones in humans and mice. Our findings provide a comprehensive, genome-wide evaluation of gene expression changes from native to cultured DRG in both humans and mice. Consistent with previous studies [18; 40] , we found that DRG neurons in culture show transcriptional signatures that suggest a neuropathic pain phenotype [5; 26] . This supports the use of cultured DRG neurons as a model system to study underlying mechanisms of pain. However, our findings point out some shortcomings of using these models to study multiple classes of receptors that show altered expression in culture. Some of these differences do not occur consistently across species, suggesting mouse Gereau lab: Human dorsal root ganglia extraction and culturing was performed as described previously (Valtcheva et al 2016) , in a similar manner to the mouse culturing protocol. Briefly, in collaboration with Mid-America Transplant Services, L4-L5 DRG were extracted from tissue/organ donors less than 2 hrs after aortic cross clamp. Donor information is presented in Table 1 . DRGs were placed in NMDG solution for transport to the lab for fine dissection. From one side, intact L4-5 DRG were directly placed into 500 μ L RNAlater, and stored at -80°C. From the other side, L4-5 DRG were minced and cultured. Pieces were dissociated enzymatically with papain and collagenase type 2 for 1hr each, and mechanically with trituration. Final solutions were filtered (100 µm, Fisher) and cultured with DRG media. On DIV4, cultured coverslips were scraped in 500μL RNAlater and stored at -80°C.
RNA sequencing
Human and mouse DRG tissue/cultured cells were stored in RNAlater and frozen in -80 °C until use. Samples obtained at the Washington University at St Louis were shipped to UT Dallas on dry ice for uniform library preparation. All RNA isolation and sequencing was done in the Price Lab. On the day of use, the frozen tubes were thawed to room temperature. To obtain RNA from tissue samples, the tissue was extracted from RNAlater with ethanol cleaned tweezers and put in 1 mL of QIAzol (QIAGEN Inc.) inside 2 mL tissue homogenizing CKMix tubes (Bertin Instruments). To obtain RNA from cell cultures, cells were spun down to the bottom of the tube by centrifuge at 5000 x g for 10 min. RNAlater was then removed from the tube, and cells were resuspended with 1 mL of QIAzol and transferred to the homogenizing tube. For both tissues and cell cultures, homogenization was performed for 3 x 1 min with Minilys personal homogenizer (Bertin Instruments) at 4 °C. This time course was used to avoid heating during homogenization. RNA extraction was performed with RNeasy Plus Universal Mini Kit (QIAGEN Inc.) with the manufacturer provided protocol. RNA was eluted with 30 µL of RNase free water.
Based on the RNA size profile determined by the Fragment Analyzer (Agilent Technologies) with the High Sensitivity Next Generation Sequencing (NGS) fragment analysis kit, we decided to sequence all human samples with total RNA library preparation and all mouse samples with mRNA library preparation. Total RNA was purified and subjected to TruSeq stranded mRNA library preparation for mouse or total RNA Gold library preparation (with ribosomal RNA depletion) for human, according to the manufacturer's instructions (Illumina). Quality control was performed for RNA extraction and cDNA library preparation steps with Qubit (Invitrogen) and
High Sensitivity NGS fragment analysis kit on the Fragment Analyzer (Agilent Technologies).
After standardizing the amount of cDNA per sample, the libraries were sequenced on an Illumina NextSeq500 sequencing platform with 75-bp single-end reads in multiplexed sequencing experiments, yielding at least 20 million reads per sample. mRNA library preparation and sequencing was done at the Genome Center in the University of Texas at Dallas Research Core Facilities.
Computational analysis
Mapping and TPM quantification: RNA-seq read files (fastq files) were checked for quality by A mouse outlier sample (sample id mDIV4-4Fg, Fig. 1 B) was similarly analyzed, but expression of neuronal marker genes was considered sufficient for retention in the analysis.
Identification of consistently detectable genes:
Previous studies on whole DRG tissue have found functional responses for GPCRs with < 0.4 TPMs (e.g. GRM2 functionally studied and abundance quantified in the papers [14; 47] ). This suggests that the approach of picking an expression threshold (in TPMs) to classify a gene either as "on" or "off" is likely to miss functionally relevant gene products based on traditional thresholds (~ 1 TPM, as in North et al [39] ). Instead, we classified consistently detectable genes based on reads being detected in the exonic region in 80% or more of the samples in a particular condition (i.e. in at least 4 of 5 human replicates, or in at least 10 of 12 mouse replicates). Assuming iid probabilities for detecting a read emanating from a particular gene in an RNA-seq experiment, this criterion causes the sensitivity of our approach to be suitable for our purpose, calling consistently detectable genes to be those that have ≥ 1 read in 7 million coding gene reads in an RNAseq library, as :
(all of our RNA-seq datasets have > 11 million reads mapping to coding gene exons) Differential expression metrics: Due to small sample sizes in humans, stringent statistical hypothesis testing using Student's t test [53] with Benjamini-Hochberg multi-testing correction
[3] yield few statistically significant differences.
We therefore decided to use strictly standardized mean difference (SSMD) to discover genes with systematically altered expression levels between experimental conditions. For each human and mouse coding gene, we report fold change and the SSMD across conditions. SSMD is the difference of means controlled by the variance of the sample measurements. We used SSMD as a secondary effect size since it is well suited for small sample sizes as in our human samples [39; 71], while simultaneously taking into account the dispersion of the data points. For determining SSMD thresholds that identify genes that are systematically changing between conditions, we use the notion of the related Bhattacharyya coefficient [6] , which is used to calculate the amount of overlap in the area under the curve of the two sample distributions in order to control for false positives in differential expression analysis. Gaussian distributions, we find that based on the Bhattacharyya coefficient, the less stringent constraint | SSMD | > 2.0 corresponds to a 36.8% overlap in the area under the curve of the two sample distributions being tested, while the more stringent | SSMD | > 3.0 corresponds to a 10.5% overlap. The less stringent criterion was used to select differentially expressed genes in gene sets of pharmacological interest, since genes with a moderate amount (< 36.8%) of overlap in TPM distributions between acutely dissociated and cultured DRG should likely not be targeted for pharmacological purposes. The more stringent constraint corresponding to little or no overlap in sample distributions (<10.5%) was used to identify differentially expressed genes at the genome wide level.
Since our data is paired, we report several variations of the standard fold change metric.
We calculated the ratio of means across conditions to compare cohort level statistics, but also calculate the mean of ratios of paired samples to better control for individual to individual variations in the transcriptome. However, the mean of ratios is more susceptible to outlier values, so we further modified it to calculate the median of ratios. All fold changes are reported as log 2 fold changes, for symmetric scaling of fold changes in both directions. Since naïve filtering or ranking by log-fold change can produce incorrect results [45], we constrain differentially expressed genes by SSMD threshold. However, we do additionally constrain that the fold change (ratio of means or median of ratios) be > 1.5, since dosage-based functional effects are unlikely to be manifested as a result of lower fold changes.
To avoid issues in calculations of these metrics for genes with no detectable reads in one or both conditions, a smoothing factor of 0.01 was added to both the numerator and denominator when calculating fold changes, and to the denominator when calculating the SSMD. We also provide uncorrected p values for paired, two sample, two tailed t tests conducted for individual genes.
These cohort and inter-cohort statistics, along with individual sample TPMs, and cohort means, are provided in Supplementary file 1, sheets 1 and 2.
Estimation of density functions:
To estimate the density functions of fold change (ratio of means) and SSMD for human and mouse pharmacologically relevant genes, we used the inbuilt k s d e n s i t y function in Matlab, using normal kernel smoothing.
Human -mouse gene orthology mapping and gene expression change comparisons across species:
Orthologous genes with a one-to-one mapping between human and mouse 1 0 families (GPCRs, ion channels, kinases) were removed from analysis if one-to-one orthology was not identified between human and mouse genes. Additionally, due to the complicated nature of the orthology map in the olfactory receptor and TAS2R families in mice and human [13; 67], these genes families were also excluded from analysis. For all remaining genes in these families that were consistently detected in human or mouse samples, a trend score was calculated by multiplying the SSMD and log median of paired fold change values. The correlation of the human and mouse trend scores were calculated using Pearson's R [42] .
Genes not systematically detected in samples of either species were left out of the analysis to avoid inflating the correlation based on the trend scores. 
Gene list compilation:

Results
Hierarchical clustering of human and mouse samples reveal whole transcriptome differences between cultured and acutely dissected DRG 1 1
We used hierarchical clustering to assess differences between RNA-seq samples analyzed in this study. As shown in Figure 1 , the top-level split of the hierarchical clustering for both human and mouse samples was between cultured and acutely dissected DRG tissue,
showing consistent whole transcriptome changes between the two. We identified broad changes in the transcriptome between acutely dissected and cultured DRGs, with 2440 human and 2941 mouse genes having a fold change (ratio of means and median of ratios) > 1.5, and | SSMD | > 3.0 between compared conditions (Supplementary file 1, sheets 1 and 2) . The smaller number of changed genes that we detect in human can be attributed to a smaller number of detected genes that increase in abundance in culture in humans compared to mouse. Of the differentially expressed genes, only 443 (18%) of the human genes and 1156 (39%) of the mouse genes have increased abundances in cultured conditions, which suggests that a majority of the differentially expressed genes gain in relative abundance in acutely dissected DRGs compared to culture. Controlled laboratory conditions and a similar genome (belonging to the same mouse strain) potentially causes lower within-group variation at the level of individual genes in the mouse samples with respect to the human samples. The smaller number of human genes detected to be increasing in culture can likely be attributed to higher within-group variation in human samples, since genes that show significantly increased expression in cultured conditions have more moderate changes (median across ratio of means in genes satisfying differential expression criterion -human: 2.8 fold, mouse: 3.5 fold) in expression compared to genes that show significantly increased expression in acutely dissected DRGs (median in human: 5.4 fold, mouse: 5.1 fold). They are therefore less likely to be detected in a lower signal to noise ratio scenario.
No distinct differences at the whole transcriptome level across sexes
In both human and mouse samples, we did not find clear sex differences at the whole transcriptome level though individual sex markers like UTY differ between the sexes (Supplementary file 1, sheets 1 and 2), consistent with previous findings [31] . Thus, male and female samples were grouped together for further analyses.
Increases in SGC and fibroblast markers compensated for by decrease in neuronal and
Schwann cell markers in human and mouse cultures
Due to the magnitude of changes, we tested whether the proportion of mRNA sourced from the different constituent cell types of the DRG were different between acutely dissected and cultured samples. We profiled the expression levels of neuronal, fibroblast, Schwann cell, SGC, and macrophage marker gene panels (chosen based on mouse single cell profiles [69]) in both human and mouse cultured and acutely dissected DRGs. We found that neuronal markers were broadly downregulated in all cultured samples from mice and humans. Expression levels of human neuronal markers in culture were decreased by a median of 8.16 fold (Fig 2A) .
Conversely, markers for human fibroblast-like cells (often of vascular origin) were increased by a median of 4.18 fold (Fig 2B) in culture compared to acutely dissected samples. We found that human myelinating Schwann cell markers (MPZ, MBP) in culture were decreased by a median of 9.88 fold compared to intact tissues (Fig 2C) but markers for human SGCs, especially proliferating SGCs (Fig 2D) , were increased (by a median of 11.60 fold). These trends were conserved in the mouse datasets as well. Since these changes happen broadly (as shown by the density function across pharmacologically relevant gene families, Fig 3) and not just in specific regulatory pathways or gene sets, they indicate that the proportion of mRNA A primary use of DRG cultures is to examine pharmacological effects of ligands for receptors with the assumption that this type of experiment reflects what occurs in vivo [35] . An underlying assumption of this type of experiment is that the presence or absence of a tested effect is reflected in consistent expression between in vivo and cultured conditions. To give insight into this assumption, we comprehensively cataloged expression of G-protein coupled receptors (GPCRs), ligand gated ion channels and receptor kinases (RKs) in native and cultured human and mouse DRG. To comprehensively characterize the changes in these gene families, we also characterized expression profiles of non-RK soluble kinases (Supplementary file 1, Sheets 3-10). We limited our soluble kinase comparisons to a well-characterized subset with clear mouse to human orthologs [32] .
We find that a number of these genes are consistently detected in acutely dissected However, it is important to note that over 75% of the human genes in these families (human: 679 out of 885, mouse: 702 out of 824) that are consistently detected in intact DRG are still detectable in culture. This suggests that at single cell resolution, DRG cultures could be used as a surrogate for in vivo models in preclinical research for a majority of pharmacologically relevant molecular assays.
Next, for genes that are systematically detected in at least one condition, we identified the ones in these gene families that have | SSMD | > 2.0 (Tables 2 and 3, for human and mouse genes). Based on the SSMD values, while comparable numbers of GPCRs, ion channels and kinases were found to be decreased in cultured DRGs (GPCRs -human: 85, mouse: 95; ion channels -human: 109, mouse: 122; kinases -human: 106, mouse: 70), more mouse genes were detected to be systematically trending in the opposite direction as compared to their human counterparts (GPCRs -human: 7, mouse: 20; ion channels -human: 7, mouse:
14; kinases -human: 22, mouse: 66). As noted before, within-group variation is likely lower in mice due to controlled laboratory conditions and similar genetic backgrounds, and this enables us to detect more expression changes that have smaller effect sizes (as in the case of genes that are increased in cultured conditions).
We also characterized the degree of change in expression by estimating the probability density of the fold change (ratio of means) for all the genes in these families. The empirically estimated probability density for the ratio of means (intact DRG: cultured DRG) of the human and mouse pharmacologically relevant genes (Figure 3) , shows a clear trend of decreased expression for a majority of the human ion channels and GPCRs.
Finally, we analyzed the trends in genes known to be involved in nociception, pain and neuronal plasticity. Genes with | SSMD | > 2.0 between conditions, and known to be associated with pain from the Human Pain Genetics Database, and the Pain -Gene association geneset Changes in human ion channels: Among the ion channels increased in abundance in cultured DRGs were the chloride intracellular channels CLIC1 and CLIC4, gap junction protein GJA1, KCNG1 (K v 6.1), KCNJ8 (K IR 6.1), KCNN4 (K Ca 4.2), and P2RX4, TRPV4, and voltage dependent anion channels VDAC1 and VDAC2. Interestingly, many of these ion channels are involved in membrane potential hyperpolarization, suggesting a potential compensatory mechanism to suppress excitability. Neuronally expressed voltage gated calcium channels such as CACNA1B, CACNA1F, CACNA1I, CACNAG5, CACNAG7 and CACNAG8; glutamate ionotropic receptors GRIA2 and GRIN1; voltage gated potassium channels KCNA1, KCNA2, KCNB2, KCNC3,
purinergic receptors P2RX2 and P2RX5; and voltage-gated sodium channels SCN1A, SCN4A, SCNN1A and SCNN1D were found to be increased in intact DRGs. ( Table 2 , and
Supplementary File 1 Sheet 5)
Changes in mouse ion channels: Changes in mouse ion channel genes were also quantified.
( 
Changes in human RKs and other kinases:
We found that the neuronally expressed genes from the NTRK family (NTRK1, NTRK2, NTRK3) and the CAMK family (CAMK1D, CAMK1G, CAMK2A, CAMK2B, CAMK2G, and CAMKK1) were decreased in culture in the human DRG.
( 4C) .
Since several of these genes are increased or decreased in cultured samples, we used the mouse DRG single cell RNA-seq profiles [58] to putatively identify cell types of expression among cells constituting the DRG (Supplementary File 1 Sheet 11) . Indeed, we find that genes primarily expressed in neurons and Schwann cells decrease in abundance, even if they are involved in pro-inflammatory signaling, since it is likely that these cells types are reduced in frequency in DRG cultures. Interestingly, several genes predicted to be primarily expressed in immune cells (TLR9, CXCR3) and in vascular cells (IL18BP, CXCL17) were found to be reduced in relative abundance in cultures, suggesting that potential increase in immune and vascular cell proportions in culture are limited to certain cell subtypes in these categories.
Multiple subtypes of macrophages are involved in inflammatory processes and can be identified with specific markers [23] . In human and mouse, key M1 macrophage genes CD68, CD80, and SOCS3 were all upregulated in culture compared to intact ganglia. As identified in a recent study, HBEGF+ inflammatory macrophages are responsible for fibroblast invasiveness in rheumatoid arthritis patients [30] . We noted that multiple genes expressed in this specific subtype of macrophage (PLAUR, HBEGF, CREM) were increased in human and mouse DRG cultures, suggesting that this particular subtype of macrophage may be present in DRG cultures from both species (Fig 4D) .
While specifically identifying the exact subtype of immune cell involved is outside the scope of our bulk RNA-sequencing assay, our findings reveal clearly that many genes involved in neuronal injury, cell proliferation and inflammation, and immune signaling and response are increased in DRG cultures.
Similarities and differences between human and mouse DRG culture transcriptomes in the context of intact DRG transcriptomes
Complicated orthologies and differential evolutionary dynamics between human and mouse gene families [67] , and gaps in human to mouse orthology annotation [37] make comparative transcriptomic comparisons difficult between human and mouse transcriptomes.
We have previously made similar comparisons between native human and mouse acutely dissected DRGs [47], finding overall similarities, but also some changes in gene expression.
Since we are analyzing changes in expression at the level of individual genes (such as pharmacologically relevant ones), we limited our analysis to changes in expression in GPCRs, ion channels, and kinases in DRG cultures for tractability.
We calculated trend scores for each GPCR, ion channel, RK, and non-RK kinase, after eliminating genes from the analysis with complicated orthologies between humans and mouse Table 4 ).
Similarity and differences between cultured DRG transcriptomes across different labs
For mouse, experiments were performed in 2 labs (Gereau lab -sample ids with a "g" suffix; and Price lab -sample ids with a "p" suffix, Figure 1B) independently. Although both labs used the same strain of mouse, both intact and cultured DRGs had a clear transcriptome difference between the two labs. This is likely caused by environmental differences between animal facilities. Additionally, while changes in gene expression levels are well known to be different across inbred mouse strains [57], recent research suggests that even for inbred mouse strains separated for over hundreds of generations, mutation profiles diverge and can cause different outcomes in molecular assays, and have been shown to cause changes in immune function related genes [11] . Surprisingly, we saw that inter-laboratory transcriptome differences in cultured mouse DRGs were smaller in cultured samples with respect to acutely dissected DRGs despite differences in culturing protocols (e.g. without nerve growth factor (NGF) in the Gereau lab, and with NGF in the Price lab). This is likely due to the fact that neurons have the most plastic molecular profiles, and putatively decline in proportion in cultured DRGs. When comparing the gene expression differences between mouse and human cultures we found some differences, consistent with our previous analysis of native DRG species differences [47] . Families of genes remained consistently expressed in both species following dissociation and culturing protocols, but individual genes of the same family varied in whether they were present in either mouse or human. For example, Kcna1 was systematically detected only in mouse DRG cultures. Therefore, while most ion channel types are likely to be equally represented in both human and mouse DRG neurons, there is a substantial chance that the specific subtypes of channels that make up those conductances will be different between species, and such changes may be present both in vivo and in culture. In fact, studies focusing on exactly this question for voltage gated sodium channels in DRG between rat and human have found qualitative similarities but key differences that are almost certainly due to differences in expression between species [70]. This is a critical distinction for pharmacology because a primary goal in therapeutic development is ion channel subtype specific targeting [46] . Our findings demonstrate that it is vital to understand these similarities and differences when 1 choosing a model system to study a particular target and, critically, we provide a comprehensive resource to do this. From a discovery perspective, studies performed in vitro in mouse neuronal cultures likely remain a valid and reliable option for researchers as the families of ion channels, GPCRs, and RKs are well conserved from mice to humans (Supplementary File 1, sheets 12-15 ).
Our study has several limitations to acknowledge. The first is the choice of time point for the cultured DRG RNA-seq studies. We chose 4 DIV for our studies. Given the literature on biochemical and Ca 2+ imaging studies (which is too extensive to cite) we think that our findings will provide a substantial resource for studies of this nature as most of them are done between 3 and 7 DIV. This can also be said for many electrophysiological studies on human DRG neurons as most investigators do experiments on these neurons over many days, with 4 DIV falling in the middle of the experimental spectrum for this small, but growing, body of work. The exception is mouse DRG electrophysiology where the vast majority of this very large literature has been done at 24 hrs after culturing. It is possible that some of the changes we observe at 4
DIV are not present at less than 1 DIV and/or that other differences are observed at this early time point. Another limitation is that changes in mRNA expression in culture may not represent differences in functional protein because some of these proteins may have long half-lives. In such a scenario, a down-regulation of mRNA would not lead to any difference in functional protein over the time course of our experiment (4 DIV). This can only be addressed with proteomic or physiological [50; 70] methods, which we have not done. Finally, we have relied on bulk RNA sequencing in the work described here. We acknowledge that single cell sequencing would yield additional insights that will be useful for the field. This will be a goal of future work. We have comprehensively characterized transcriptomic changes between native and cultured mouse and human DRG. Our overarching conclusion is that these tissues are similar between the two species, suggesting that discovery work that is largely done in mice faithfully models many physiological characteristics of human DRG neurons. However, there are important differences between species and between native and cultured conditions, with minimal impact of the type of culturing protocol used. Our resource brings these differences to light allowing for appropriate model system choice and delineation of pharmacological divergences. i  e  m  i  J  P  ,  D  e  F  r  a  n  c  e  s  c  o  -L  i  s  o  w  i  t  z  A  ,  R  o  l  d  a  n  -H  e  r  n  a  n  d  e  z  L  ,  L  i  n  d  b  o  r  g  J  A  ,  M  a  n  d  e  l  l  D  ,   Z  i  g  m  o  n  d  R  E  .  A  c  r  i  t  i  c  a  l  r  o  l  e  f  o  r  m  a  c  r  o  p  h  a  g  e  s  n  e  a  r  a  x  o  t  o  m  i  z  e  d  n  e  u  r  o  n  a  l  c  e  l  l  b  o  d  i  e  s  i  n   s  t  i  m  u  l  a  t  i  n  g  n  e  r  v  e  r  e  g  e  n  e  r  a  t  i  o  n  .  J  N  e  u  r  o  s  c  i  2  0  1  3  ;  3  3  (  4  1  )  :  1  6  2  3  6  -1  6  2  4  8  .   [  3  9  ]  N  o  r  t  h  R  Y  ,  L  i  Y  ,  R  a  y  P  ,  R  h  i  n  e  s  L  D  ,  T  a  t  s  u  i  C  E  ,  R  a  o  G  ,  J  o  h  a  n  s  s  o  n  C  A  ,  Z  h  a  n  g  H  ,  K  i  m  Y  H 
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